Extracorporeal membrane oxygenation for tuberculosis pneumonia with empyema

Acute respiratory distress syndrome (ARDS) caused by Mycobacterium Tuberculosis (TB) is a rare entity. Extracorporeal membrane oxygenation (ECMO) therapy had been used as an effective therapy for this cases, but the evidence is scarce. We present a case that took place in the middle of SARS-CoV2 pan...

Full description

Saved in:
Bibliographic Details
Published in:Respiratory medicine case reports 2021-01, Vol.34, p.101481, Article 101481
Main Authors: Besa, Santiago, Morales, Álvaro J., Salas, Patricio, Bravo M, Sebastián, Garrido-Olivares, Luis
Format: Article
Language:English
Subjects:
Acute respiratory failure
Case Report
ECMO
Empyema
Tuberculosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Acute respiratory distress syndrome (ARDS) caused by Mycobacterium Tuberculosis (TB) is a rare entity. Extracorporeal membrane oxygenation (ECMO) therapy had been used as an effective therapy for this cases, but the evidence is scarce. We present a case that took place in the middle of SARS-CoV2 pandemic. A 33-year-old female presented with ARDS due to pulmonary TB infection (pneumonia with empyema and pneumothorax), which required invasive mechanical ventilation with poor response. Long term veno-arterio-venous (VAV) ECMO, overlapped with veno-venous ECMO, was used as a salvage therapy with a good response for a total of 26 days. This is an example of the effectiveness of this therapy in this scenario, never described before. The fact that this therapy was used in the middle of SARS-CoV2 pandemic, with limited resources available, was remarkable, but it was encouraged by previous successful experiences.
ISSN:2213-0071
2213-0071
DOI:10.1016/j.rmcr.2021.101481